1. Home
  2. JAZZ vs SGI Comparison

JAZZ vs SGI Comparison

Compare JAZZ & SGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

N/A

Current Price

$242.66

Market Cap

16.1B

Sector

Health Care

ML Signal

N/A

Logo Somnigroup International Inc.

SGI

Somnigroup International Inc.

N/A

Current Price

$60.04

Market Cap

13.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
JAZZ
SGI
Founded
2003
1846
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
16.1B
13.3B
IPO Year
2007
2003

Fundamental Metrics

Financial Performance
Metric
JAZZ
SGI
Price
$242.66
$60.04
Analyst Decision
Buy
Strong Buy
Analyst Count
22
11
Target Price
★ $297.50
$85.40
AVG Volume (30 Days)
691.1K
★ 3.1M
Earning Date
11-02-2026
11-09-2026
Dividend Yield
N/A
★ 1.17%
EPS Growth
N/A
★ N/A
EPS
0.04
★ 1.76
Revenue
$1,618,693,000.00
★ $2,754,400,000.00
Revenue This Year
$12.68
$15.75
Revenue Next Year
$5.34
$29.47
P/E Ratio
$6,014.25
★ $33.05
Revenue Growth
N/A
N/A
52 Week Low
$156.95
$57.94
52 Week High
$266.38
$98.56

Technical Indicators

Market Signals
Indicator
JAZZ
SGI
Relative Strength Index (RSI) 61.11 42.66
Support Level $236.70 N/A
Resistance Level $250.49 $71.33
Average True Range (ATR) 7.43 2.96
MACD 2.04 -0.70
Stochastic Oscillator 81.96 17.60

Price Performance

Historical Comparison
JAZZ
SGI

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About SGI Somnigroup International Inc.

Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.

Share on Social Networks: